drugset / Trial / NCT00411411

Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes

NCT00411411

RandomizedParallel-groupDouble-blindTreatment

Summary

We wish to evaluate the effect of long term treatment with a DPP-IV inhibitor on the function of the incretin hormones Hypothesis We hypothesize that that a gradual improvement in metabolic control induced by DPP-IV inhibitor (Januvia®) treatment significantly ameliorates the impaired secretion and potency of GLP-1 and leads to a restoration of the lost action of GIP.

Timeline

Start
2007-02
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 200 mg Oral